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Lung  ischaemia–reperfusion-induced  oedema  (LIRE)  is  a  life-threatening  condition  that 
causes pulmonary oedema induced by endothelial dysfunction. Here we show that lungs from   
mice  lacking  nicotinamide  adenine  dinucleotide  phosphate  (nADPH)  oxidase  (Nox2y/ − ) 
or the classical transient receptor potential channel 6 (TRPC6 − / − ) are protected from LIR-
induced oedema (LIRE). Generation of chimeric mice by bone marrow cell transplantation and   
endothelial-specific nox2 deletion showed that endothelial nox2, but not leukocytic nox2 or 
TRPC6, are responsible for LIRE. Lung endothelial cells from nox2- or TRPC6-deficient mice 
showed attenuated ischaemia-induced Ca2 +  influx, cellular shape changes and impaired barrier 
function. Production of reactive oxygen species was completely abolished in Nox2y/ −  cells. 
A novel mechanistic model comprising endothelial nox2-derived production of superoxide, 
activation  of  phospholipase  C-γ,  inhibition  of  diacylglycerol  (DAG)  kinase,  DAG-mediated 
activation of TRPC6 and ensuing LIRE is supported by pharmacological and molecular evidence. 
This mechanism highlights novel pharmacological targets for the treatment of LIRE. 
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L
ung ischaemia–reperfusion oedema (LIRE) is one of the most   
common and significant causes of morbidity and mortality 
after lung transplantation, thrombarterectomy and acute lung 
embolism1. LIRE typically results in massive damage of the microv-
ascular endothelium, lung oedema and consequent organ dysfunc-
tion, and despite considerable progress in the management of this 
disorder,  the  molecular  mechanism  underlying  its  development 
remains unclear1. Early during LIRE, there is a rise in reactive oxygen   
species (ROS)2 and intracellular Ca2 +  concentration ([Ca2 + ]i) in 
endothelial cells3. This has been proposed to be an initial step in the 
pathogenesis of injury, which would then lead to a change in cell 
morphology  and  increased  endothelial  permeability4,5,  followed 
by the subsequent extravasation of plasma, macromolecules and 
immune cells. However, the contribution of different cell types to 
this process and the underlying signalling cascade are still elusive. 
In particular, the question of how ROS production and endothelial 
[Ca2 + ]i is regulated in LIRE has not yet been answered.
Although a ‘burst’ of ROS during LIRE has been observed by many   
investigators2, the major source of ROS production remains unclear. 
One likely candidate is the nicotinamide adenine dinucleotide phos-
phate (NADPH)-dependent oxidase that is present in the plasma 
membrane of the polymorphonuclear (PMN) leukocytes6 and con-
tains six subunits: rac1 or rac2 and five phox proteins. The catalytic 
core of the enzyme is located in the Nox2 protein (also known as 
gp91phox), which also contains the heme molecule6. Although a 
deleterious role for circulating PMN leukocytes in LIRE has been 
inferred from the protective effect of depletion of PMN leukocytes7 
and from the reduction in injury following inhibition of adhesion 
molecules8, the role of resident lung leukocytes in LIRE remains con-
troversial9–11. In addition to leukocytes, a phagocyte-type NADPH 
oxidase expressed in endothelial cells is a major contributor to the 
overall vascular ROS production and has a key role in vascular 
oxidative stress12. Although ROS derived from vascular NADPH 
oxidase  have  been  implicated  in  the  pathophysiology  of  many 
cardiovascular  diseases,  including  atherosclerosis,  hypertension,   
diabetic vasculopathy and heart failure, their role in LIRE remains 
undefined.
Transient receptor potential (TRP) channels are regulators of 
[Ca2 + ]i in many tissues, including vascular smooth muscle and 
endothelium, and may be crucial contributors to the rise in endothe-
lial [Ca2 + ]i during LIRE. The TRP protein superfamily consists of a 
diverse group of non-selective cation channels involved in many basic 
cellular processes13. Although the members of the TRPV (for vanil-
loid) and TRPM (for melastatin) subfamilies have emerged as versatile 
cellular sensors, the functional importance of the seven members of 
the TRPC (for classical) channel subfamily (TRPC1–7) is still poorly 
understood13. Among the TRPC channels, TRPC3, 6 and 7 share 69% 
identity and are gated by pathways involving C-type phospholipases 
(PLCs) and by direct exposure to diacylglycerols (DAG)14. TRPC6 is 
highly expressed in the lung, and we recently demonstrated that it has 
an essential role during acute hypoxic vasoconstriction15. Recent stud-
ies have demonstrated that TRPC6 represents a target of ROS in differ-
ent disease models16–19. Furthermore, there is evidence that TRPC6   
is involved in thrombin-induced Ca2 +  entry into endothelial cells and 
a subsequent change of cell shape20. Therefore, our data propose a 
mechanistic model in which ROS production by activated endothelial 
NOX2 leads to PLCγ activation, DAG kinase inhibition and subse-
quent TRPC6 activation as successive events resulting in LIRE.
Results
Nox2 and TRPC6 induce vascular permeability after reperfusion. 
To address the importance of Nox2 in LIR-induced oedema (LIRE), 
we analysed isolated lungs from wild-type (WT) and Nox2-deficient 
(Nox2y/ − ) mice21 (Supplementary Methods). After 90 min of ischae-
mia and application of three hydrostatic challenge manoeuvres at 
30, 60 and 90 min after reperfusion, WT lungs showed enhanced 
vascular permeability, as evidenced by a considerable gain in lung 
weight  (Fig.  1a)  and  an  increased  capillary  filtration  coefficient 
(Kfc) (Fig. 1b). By contrast, lungs isolated from Nox2y/ −  mice were 
almost completely protected from ischaemia–reperfusion-induced 
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Figure 1 | Analysis of LIRE in WT and Nox2-deficient lungs, as well as in mice with deficiency for Nox2 in either cells of the myeloid lineage or  
in endothelial cells. (a,b and e–h) Post-ischaemic vascular leakage in isolated lungs. (a,e,g) Lung weight gain was calculated as the weight  
difference before and after each hydrostatic challenge manoeuvre. (b,f,h) The lung Kfc was determined before ischaemia and at 30-min intervals after 
re-establishing perfusion. (c) Analysis of ischaemia–reperfusion-induced pulmonary oedema formation in living mice. Pulmonary oedema formation 
was analysed by quantitative assessment of wet-to-dry weight ratios of ischaemia-exposed lungs, normalized to sham-operated mice. (d) Intravascular 
superoxide release in isolated lungs ± apocynin. (e–h) myeloid nox2y/ −  ( = nox2-flox-flox-LysmCre- + /0) were compared with nox2-flox-flox- 
LysmCre-0/0 mice as controls. Endothelial nox2y/ −  ( = nox2-flox-flox-ERT2-Tie2- + /0) was compared with nox2-flox-flox-ERT2-Tie2-0/0 as controls. 
Values from each mouse line with or without tamoxifen induction are indicated. (a,b and e–h) n = 4–6. Data were statistically analysed by student’s t-test 
with Welsh’s correction for comparisons of two groups and one-way analysis of variance with the student–newman–Keuls test for multiple comparisons. 
All data are presented as mean ± s.e.m.; *P < 0.05. For (d) *indicates significant differences compared with ‘normoxia’.ARTICLE     
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increase  in  organ  weight  (Fig.  1a)  and  in  Kfc  values  (Fig.  1b).   
In non-ischaemic lungs, Kfc values were essentially constant and 
only marginal lung weight gains were observed throughout the entire 
experimental  period  (Fig.  1a,b).  The  NADPH  oxidase  inhibitor 
and antioxidant apocynin significantly attenuated vascular leakage 
and reduced lung oedema after ischaemia–reperfusion, similarly 
to Nox2 deficiency (Fig. 1a,b). In contrast, mice deficient in Nox1 
or Nox4 were not protected from LIRE, but showed lung weight 
gain (Supplementary Fig. S1a) and increased Kfcs (Supplementary   
Fig. S1b), similar to WT mice.
We next investigated lung oedema formation in vivo, in intact 
anaesthetized mice during ischaemia–reperfusion. Although WT 
mice developed severe oedema, Nox2y/ −  mice did not (Fig. 1c). 
Moreover, total intravascular superoxide release following ischae-
mia–reperfusion was increased in lungs from WT mice compared 
with lungs from time-matched non-ischaemic controls (Fig. 1d). By 
contrast,  intravascular  superoxide  release  after  ischaemia–reper-
fusion was reduced in lungs from apocynin-treated mice or Nox2y/ −  
mice compared with those from WT mice. The cellular sources of 
the different mediators that are suggested to contribute to the induc-
tion of LIRE is a matter of ongoing controversy10,11,22–24. We thus 
examined whether the role of NADPH oxidase in circulating and 
resident leukocytes was different from that of NADPH oxidase in 
endothelial cells. To this end, we created chimeric mice by trans-
planting Nox2y/ −  bone marrow cells into lethally irradiated WT 
mice (Nox2y/ −  to WT chimera) and vice versa (WT to Nox2y/ −  
chimera). Isolated lungs from Nox2y/ −  to WT chimeras showed an 
increase in lung weight (Supplementary Fig. S1c) and Kfc values 
(Supplementary Fig. S1d) following ischaemia–reperfusion, similar 
to lungs from non-chimeric WT mice and control WT mice trans-
planted with WT bone marrow (WT to WT chimera). However, WT 
to Nox2y/ −  chimeric mice did not develop increased vascular per-
meability after ischaemia–reperfusion (Supplementary Fig. S1c,d).   
Moreover,  Nox2-deficency  exclusively  in  the  myeloid  lineage 
resulted in lung weight gain and increased Kfc values similar to 
WT  conditions,  whereas  endothelial  cell-specific  Nox2  inactiva-
tion protected from LIRE (Fig. 1e–h). Therefore, it is the endothelial 
Nox2 function that is most likely responsible for the induction of 
LIRE. Consistently, bronchoalveolar lavage cells from Nox2y/ −  and   
myeloid  Nox2-deficient  mice  did  not  release  superoxide  upon 
NADPH oxidase stimulation, whereas those from WT mice did 
(Supplementary Fig. S2).
To elucidate the role of TRPC6 in LIRE, we analysed TRPC6 − / −  
mice in a way similar to that described for Nox2y/ −  mice. Lungs 
isolated from TRPC6 − / −  mice displayed no significant changes in 
weight gain (Fig. 2a) and Kfc values (Fig. 2b) following ischaemia–
reperfusion.
The  specific  contribution  of  TRPC6  to  pulmonary  oedema 
is underlined by the fact that lungs from TRPC1-25 and TRPC4- 
deficient mice26 were not protected from increased vascular perme-
ability caused by ischaemia–reperfusion (Fig. 2c,d).
To differentiate between the role of TRPC6 in circulating and 
resident leukocytes versus that in endothelial cells, TRPC6 − / −  bone 
marrow cells were transplanted into lethally irradiated WT mice 
(TRPC6 − / −  to WT chimera) and vice versa (WT to TRPC6 − / −  chi-
mera; Supplementary Methods). Isolated lungs from TRPC6 − / −  to 
WT chimeric mice responded to ischaemia–reperfusion with a lung 
weight gain (Fig. 2e) and increased Kfc values (Fig. 2f), similarly to 
lungs from non-chimeric WT mice and WT to WT chimeras. By 
contrast, WT to TRPC6 − / −  chimeric mice did not develop increased 
vascular permeability after hydrostatic challenge (Fig. 2e,f), sug-
gesting that TRPC6 function in non-bone marrow-derived cells—
and thus likely in endothelial cells—is important for the develop-
ment of LIRE. Moreover, TRPC6 − / −  mice were also protected from 
lung oedema formation caused by ischaemia–reperfusion in vivo  
(Fig. 2g). For details and variations of the ischaemia–reperfusion 
protocol, see Materials and Methods and Supplementary Figure S3.
The extent of protection from LIRE was very similar between 
Nox2y/ −   and  TRPC6 − / −   mice.  On  the  basis  of  recent  findings 
that  TRPC6  represents  a  target  for  ROS  derived  from  NADPH   
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Figure 2 | Analysis of LIRE in WT and TRPC-deficient (TRPC1 − / − , TRPC4 − / − and TRPC6 − / − ) lungs. (a,b) Post-ischaemic vascular leakage in isolated 
lungs of WT and TRPC6 − / −  mice, (c,d) TRPC1- and TRPC4-deficient animals, and (e,f) chimeric mice. (g) Analysis of ischaemia–reperfusion-induced 
pulmonary oedema formation in living mice. (a,c,e) Lung weight gain was calculated as the weight difference before and after each hydrostatic challenge 
manoeuvre. (b,d,f). The lung Kfc was determined before ischaemia and at 30-min intervals after re-establishing perfusion. (e,f) Post-ischaemic vascular 
leakage in isolated lungs of chimeric mice, in which bone marrow cells of WT or TRPC6 − / −  mice were transplanted to irradiated WT mice, or bone 
marrow cells of TRPC6 − / −  to irradiated WT mice. If 90-min values are not displayed, experiments had to be terminated before, because of excessive 
oedema formation. (g) Pulmonary oedema formation in living mice was analysed by quantitative assessment of wet-to-dry weight ratios of ischaemia-
exposed lungs normalized to sham-operated mice. (a–g) n = 4–7. Data were statistically analysed by student’s t-test with Welsh’s correction for 
comparison of two groups and one-way analysis of variance with the student–newman–Keuls test for multiple comparisons. All data are presented as 
mean ± s.e.m.; *P < 0.05.ARTICLE
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oxidases17–19, we reasoned that Nox2 and TRPC6 proteins might 
be components of the same signal transduction pathway leading to 
lung oedema.
Nox2 produces superoxide raising [(Ca2 + )i] via TRPC6. To inves-
tigate the role of Nox2 and TRPC6 at the cellular level, we isolated 
primary murine lung endothelial cells (MLEC) from WT, Nox2y/ −  
and TRPC6 − / −  mice. MLEC were identified by staining with anti-
bodies directed against von Willebrand factor and platelet endothe-
lial  cell  adhesion  molecule-1  (Fig.  3a).  In  immunoblots  using  a 
TRPC6-specific antiserum, TRPC6 protein was detected in lysates 
of WT endothelial cells, but not in TRPC6 − / −  endothelial cells   
(Fig. 3b). As TRPC6 deficiency might be compensated for by upregu-
lation of closely related members of the TRPC family27, we assessed 
the expression of TRPC subtypes in primary MLEC. Quantitative 
reverse-transcription PCR analysis revealed predominant expres-
sion of TRPC1, TRPC4 and TRPC6 mRNA in MLEC from WT 
mice (Supplementary Methods). A compensatory upregulation of 
other TRPC subtypes in TRPC6 − / −  MLEC was not observed (Sup-
plementary Figure S4a). Moreover, hypoxia or application of H2O2 
did not induce any changes in the TRPC-expression pattern in WT 
endothelial cells (Supplementary Fig. S4b), nor did H2O2 (100 µM) 
activate TRPC6 directly in endothelial cells.
In line with our findings in intact lungs, WT cells reacted to 
ischaemic conditions with superoxide release into the extracellular 
medium, whereas Nox2y/ −  MLEC were unresponsive (Fig. 3c) when 
compared with normoxic conditions as monitored by electron spin 
resonance (ESR) spectroscopy applying an extracellular spin probe.
Using the H2O2-specific HyPer detection method, WT cells dis-
played a rise of intracellular H2O2 levels after ischaemia–reperfusion. 
This increase was completely abolished in Nox2y/ −  MLEC (Fig. 3d). 
In line with the assumption of extracellularly released superoxide 
being converted to H2O2, diffusing into MLEC to increase intrac-
ellular H2O2 levels in ischaemia, extracellular catalase significantly 
reduced, but extracellular superoxide dismutase increased intracel-
lular H2O2 levels (Supplementary Fig. S5a). This finding was fur-
ther substantiated by employing amplex red as a fluorescence probe 
specific for extracellular H2O2 (Supplementary Fig. S5d). Moreover, 
our data show that ROS levels were already rising during ischae-
mia, but do not further increase during reperfusion (Supplementary   
Fig. S5a–c).
In  addition,  after  ischaemia–reperfusion,  [Ca2 + ]i  was  signifi-
cantly decreased in Nox2y/ −  cells compared with WT cells (Fig. 3e),   
prompting  us  to  investigate  Ca2 +   entry  pathways  in  MLEC   
(Supplementary Methods).
The increase in [Ca2 + ]i elicited by ischaemic incubation of WT 
MLEC was significantly decreased in MLEC from TRPC6 − / −  mice 
(Fig. 3f). To differentiate between Ca2 +  influx and release of Ca2 +  
from internal stores, we monitored TRPC6 activity in MLEC by 
analysing  ischaemia-induced  Mn2 +   influx.  Ischaemia  initiated  a 
marked influx of cations from the extracellular space in WT, but not 
in TRPC6 − / −  MLEC (Fig. 3g and inset). As store-operated Ca2 +  
channels and capacitative calcium entry through TRPC4 have been 
suggested to contribute to the regulation of [Ca2 + ]i in endothelial 
cells4,5, we investigated the role of internal Ca2 +  stores in the ischae-
mia-induced increase in [Ca2 + ]i. In contrast to previous reports4,5, 
we  found  that  ischaemia-induced  elevation  of  [Ca2 + ]i  does  not 
depend on Ca2 +  release from internal stores, because ischaemia-
induced increases in [Ca2 + ]i were not detectable in the absence of 
extracellular Ca2 +  (Supplementary Fig. S6a). However, both WT 
and TRPC6 − / −  cells responded to thapsigargin by a comparable 
Ca2 +  release from intracellular stores (Supplementary Fig. S6b).
Endothelial  cells  are  generally  viewed  as  being  electrically   
non-excitable. In keeping with this notion, addition of nicardipine 
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(10 µM)  to  isolated  lungs  failed  to  prevent  LIRE  in  WT  lungs, 
whereas  SKF-96365  (50 µM),  an  inhibitor  of  receptor-mediated 
Ca2 +  entry, significantly reduced vascular permeability (Supple-
mentary Fig. S7).
To assess ischaemia-induced membrane currents through TRPC 
channels directly, we measured cationic currents in MLEC (Supple-
mentary Methods). Ischaemia increased both inward and outward 
currents in MLEC from WT mice (Fig. 3h), but not in MLEC from 
Nox2y/ −  and TRPC6 − / −  mice (Fig. 3i,j). Under normoxic condi-
tions, exposure to oleoylacetylglycerol (OAG), a membrane-per-
meable analogue of the TRPC3/6/7 channel activator DAG, as well 
as the TRPC6 activator flufenamic acid, resulted in a significant 
increase in current densities in MLEC from WT and Nox2y/ −  mice 
(Fig. 3i,j), but not in those from TRPC6 − / −  mice (Fig. 3j).
TRPC6 controls endothelial cell permeability. Changes in endo-
thelial  barrier  function  were  determined  by  analysing  cellular   
resistance of WT and TRPC6 − / −  endothelial cells under flow con-
ditions. Cellular resistance was profoundly decreased in response to 
ischaemia in WT MLEC, whereas TRPC6 − / −  and Nox2y/ −  MLEC 
were significantly less affected (Fig. 4a). The TRPC6 activator OAG 
was able to increase endothelial permeability in WT and Nox2y/ −  
MLEC,  but  not  in  TRPC6 − / −   cells  (Fig.  4b).  Moreover,  MLEC 
from TRPC6 − / −  mice expressing a recombinant TRPC6 fused to 
the enhanced green fluorescent protein (eGFP) reacted to ischae-
mia  with  a  significantly  pronounced  decrease  in  cell  monolayer 
resistance, compared with cells transfected with eGFP cDNA alone, 
emphasizing an essential role of TRPC6 for endothelial cell shape 
change (Fig. 4c).
Involvement of PLCγ phosphorylation in LIRE. To identify further   
proteins and signalling steps involved in the transduction cascade 
from the production of ROS by Nox2 to the activation of TRPC6 
channels, we examined the effect of a PLC inhibitor on LIRE in iso-
lated lungs. Although the active PLC inhibitor (U73122) completely 
abolished LIRE, an inactive analogue (U73343) did not suppress 
LIRE (Fig. 5a,b). In vivo, anaesthetized WT mice exposed to the 
solvent dimethyl sulfoxide developed severe lung oedema following 
ischaemia–reperfusion;  however,  U73122-treated  WT  mice  were 
protected  (Fig.  5c).  In  additional  experiments,  we  excluded  any 
inhibitory effects of U73122 on TRPC6 activity.
As phosphorylation and subsequent activation of PLCγ by H2O2 
has been shown in renal artery vascular smooth muscle cells28, we 
investigated whether this also occurs in lungs using a phosphoryla-
tion-specific PLCγ antibody. Only moderate levels of phosphorylated 
PLCγ were detectable during normoxia, but ischaemia–reperfusion 
induced a significant increase in phosphorylated PLCγ in WT, but 
not in Nox2-deficient lungs (Fig. 5d,e). Moreover, H2O2 was able to 
induce PLCγ phosphorylation in MLEC (Fig. 5f,g). Like all other 
PLC isozymes, PLCγ cleaves phosphatidylinositol-4,5-bisphosphate 
into inositol-1,4,5-trisphosphate and DAG. Therefore, we investi-
gated whether ischaemia would induce DAG accumulation at the 
plasma membrane of endothelial cells, necessary to activate TRPC6. 
We took advantage of a fluorescent DAG-sensor, consisting of the 
DAG-binding C1 domain of protein kinase Cδ29 fused to eGFP, to 
monitor changes in the local distribution of cellular DAG contents 
in response to ischaemia. In WT MLEC, the DAG sensor was local-
ized in the cytosol under normoxic conditions, but under ischae-
mic conditions, DAG-dependent fluorescence redistributed to the 
plasma membrane (Fig. 5h,i). This effect was fully reversible after 
normoxic perfusion (Fig. 5i).
DAG  kinase  activity  reduces  ischaemia-reperfusion-induced 
TRPC6 activation. DAG is an important second messenger in the 
cell and is rapidly degraded by cellular enzymes. In particular, DAG 
kinases metabolize DAG to phosphatidic acid30, representing the 
main route to inactivate DAG. To analyse the role of DAG kinases 
in LIRE, we used R59949, a potent enzyme inhibitor. Application of 
R59949 resulted in a rise of [Ca2 + ]i in WT MLEC, whereas TRPC6 − / −  
MLEC were completely unresponsive (Fig. 6a). As these data point 
to a role of DAG kinases in the regulation of TRPC6 activity, we 
analysed the expression pattern of DAG kinases in endothelial cells. 
Among the DAG kinases tested, the α and η isozymes were promi-
nently expressed in endothelial cells (Fig. 6b). Using an in vitro assay 
(Supplementary Methods) in which the DAG kinase isoforms α, β, 
γ and η are expressed heterologously in HEK293 cells, we analysed 
their sensitivity to H2O2. Although metabolism of DAG by the α, β  
and γ isoforms was unchanged after application of H2O2, the enzy-
matic activity of both η isoforms was markedly inhibited (Fig. 6c). 
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Therefore,  we  overexpressed  exogenous  DAG  kinase  η1  and  η2  
isoforms fused to eGFP in WT MLEC and assessed Ca2 +  influx 
following  ischaemia–reperfusion  in  these  cells  in  comparison   
with cells transfected with the eGFP cDNA alone. As expected, 
expression  of  DAG  kinase  η1 + 2  was  able  to  suppress  [Ca2 + ]i 
increases in endothelial cells (Fig. 6d).
To further substantiate our hypothesis that both DAG accumula-
tion by PLCγ and DAG kinase inhibition are essential for TRPC6 
* * *
*
* *
Kfc (cm 3  / (s × mm Hg × g × 10 4 ))
0
4
8
12
16
Lung weight gain (g)
0 30 60 90
MLEC
Wet-to-dry weight ratio gain
WT +
U73122 
WT +
DMSO 
0
1
2
3
4
5 *
WT
WT
Normoxia
Control
Normoxia
Ischaemia/
reperfusion
Ischaemia/
reperfusion
0
0.1
0.2
0.4
0.5
0.3
*
Control
R
a
t
i
o
 
f
l
u
o
r
e
s
c
e
n
c
e
m
e
m
b
r
a
n
e
 
/
 
c
y
t
o
s
o
l *
*
0
0.1
0.2
0.3 *
150
150
kD
kD
150
150
0.0
0.2
0.4
0.6 WT + U73122
WT + U73343
Pre
Time after reperfusion (min)
0 30 60 90 Pre
Time after reperfusion (min)
WT + U73343
WT + U73122
Ischaemia
90 min
Ischaemia
90 min
H2O2
pPLCγ
PCγ
pPLC γ
PLCγ
R
a
t
i
o
 
p
P
L
C
γ
 
/
 
P
L
C
γ
 
R
a
t
i
o
 
p
P
L
C
γ
 
/
 
P
L
C
γ
 
Nox2
y/–
Normoxia
Ischaemia/
reperfusion
Normoxia
Ischaemia/
reperfusion
H2O2
0.0
0.5
1.0
1.5
2.0
2.5
3.0
Normoxia
Ischaemia
Normoxia
Figure 5 | Activation of C-type phospholipase (PLC) and accumulation of DAG during ischaemia–reperfusion in isolated lungs and MLEC. (a and b) 
Post-ischaemic vascular leakage in isolated lungs of WT mice undergoing ischaemia–reperfusion with application of the PLC inhibitor u73122 and its non-
functional analogue u73343. (a) WT lung weight gain. (b) Lung Kfc of WT lungs. (c) Pulmonary oedema formation in living mice  ± u73122 normalized 
to sham-operated mice. (d) Immunoblot of protein lysates of normoxic and ischaemic lungs from WT (WT) and nox2-deficient (Nox2y/ − ) mice with 
a phosphospecific PLCγ antibody (pPLCγ) and a PLCγ antibody (e) Quantitative analysis of PLCγ phosphorylation. (f) Immunoblot of protein lysates 
of mLEC ± H2o2 (100 µm; for 5 min) incubated with a pPLCγ and a PLCγ antibody. (g) Quantitative analysis of PLCγ phosphorylation in control mLEC 
and mLEC treated with H2o2. (h) Fluorescence images of mLEC expressing a fluorescent DAG sensor. scale bars correspond to 10 µm and arrows are 
indicating plasma membrane staining. (i) summarized data for the ratios of plasma membrane versus cytosolic fluorescence intensities of WT mLEC. 
(a–c) n = 5. (i) n = 5 cells. All statistical data were assessed using student’s t-test with Welsh’s correction and are presented as mean ± s.e.m.; *P < 0.05.
0.00
DAG
kinase
0.04
0.08
0.12
0.16
0.20
Percentage of reference 
gene expression
α
Lung endothelial cells
H2O2 – + – + – +
DAG
kinase
α β
H2O2 – + – +
DAG
kinase
η1 η2
γ
0
200
400
600
800
0
2,000
4,000
6,000
8,000
10,000
Time (min)
0 5 10 15 20 25 30 35 40 45
1.8
1.6
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0
Ischaemia
= + DAG kinase η1+2 − eGFP
WT
R59949 (100 µM)
TRPC6
–/–
Time (min)
1 2 3 4
0.4
0.5
0.6
0.7
0.8
0.9
1.0
1.1
*
* *
R
a
t
i
o
 
3
4
0
/
3
8
0
c
p
m
 
(
a
r
b
i
t
r
a
r
y
 
u
n
i
t
s
)
c
p
m
 
(
a
r
b
i
t
r
a
r
y
 
u
n
i
t
s
)
R
a
t
i
o
 
3
4
0
/
3
8
0
β γ η1-2
= + eGFP
Hypox.
Perf. No perfusion
Norm.
Perf.
Figure 6 | Influence of DAG kinase activity on ischaemia-induced increases in [Ca2 + ]i. (a) Effects of the DAG kinase inhibitor II (R59949) on the 
[Ca2 + ]i in WT versus TRPC6-deficient (TRPC6 − / − ) mLEC. (b) Quantification of mRnAs encoding DAG kinases to β-actin (as reference gene) with the 
aid of a light cycler. (c) In vitro assay for DAG kinase α, β, γ and η activity ± pre-incubation with H2o2 (100 µm). (d) Cation influx in mLEC from WT cells 
electroporated with DAG kinase η1 and η2 fused to the eGFP ( + DAG kinase η1 + 2-eGFP) and eGFP alone ( + eGFP). n. norm., normoxia; Perf., perfusion.  
(a) n = 42–61 cells (b) mLEC from n = 5 mice. (c) n = 3 independent experiments. (d) n = 76–104 cells. All statistical data were assessed using student’s 
t-test with Welsh’s correction and are presented as mean ± s.e.m.; *P < 0.05.ARTICLE     

nATuRE CommunICATIons | DoI: 10.1038/ncomms1660
nATuRE CommunICATIons | 3:649 | DoI: 10.1038/ncomms1660 | www.nature.com/naturecommunications
© 2012 Macmillan Publishers Limited. All rights reserved.
activation in the early stages of LIRE, we examined isolated WT 
lungs after ischaemia–reperfusion or normoxia in the presence of 
OAG  and/or  DAG-kinase  inhibitor.  OAG  enhanced  ischaemia–
reperfusion-induced vascular permeability significantly in isolated   
WT lungs and induced lung oedema in Nox2y/ −  mice during ischae-
mia–reperfusion,  compared  with  lungs  treated  with  the  solvent   
dimethyl sulfoxide (Fig. 7a,b). Furthermore, non-ischaemic lungs 
developed oedema comparable to LIRE lungs when both OAG and 
DAG-kinase inhibitor were applied (Fig. 7a,b).
Discussion
Impaired  endothelial  barrier  function  with  subsequent  oedema 
formation and organ failure is the characteristic feature in early 
stages of LIRE. However, the molecular steps involved in the loss 
of endothelial integrity and subsequent oedema formation are still 
poorly understood. We report evidence to support a mechanistic 
model of LIRE in mice involving a sequence of events starting with 
increased  endothelial  ROS  production  by  activated  endothelial 
Nox2, leading to PLCγ activation, DAG kinase inhibition and sub-
sequent DAG-mediated TRPC6 activation. To differentiate between 
the  role  of  Nox2  in  leukocytic  versus  endothelial  cells,  Nox2y/ −  
bone marrow cells were transplanted into lethally irradiated WT 
mice and vice versa.
Next, we investigated mice deficient of Nox2 in cells of the mye-
loid lineage or specifically in endothelial cells. These experiments 
supported the notion that endothelial, but not leukocytic Nox2, 
function protects from LIRE. Corresponding results were obtained 
with chimeric TRPC6 − / −  mice. The results from the ex-vivo lung 
experiments were corroborated in an in-vivo mouse lung ischae-
mia–reperfusion model. These findings are in contrast to findings 
that depletion of alveolar macrophages protects against LIRE10,31. 
However,  depletion  of  macrophages  by  clodronate  liposomes  or 
gadolinium chloride can have effects beyond macrophage deple-
tion, like inhibition of ion channels and an increase in the lung-
surfactant pool, which can explain protection from LIRE besides 
the  effect  on  macrophages32–37.  Although  we  show  a  complete 
protection from LIRE by deletion of endothelial Nox2, Yang et al.24 
recently showed partial protection from LIRE by deletion of p47phox 
in bone marrow cells. This partial effect on LIRE may be explained 
by the fact that lungs were exposed to a much shorter ischaemic 
period, so that injury particularly in early reperfusion was much 
milder than in our experiments. Along these lines, it can be sug-
gested that endothelial Nox2 triggers the initial event of LIRE and 
that bone marrow-derived NADPH oxidases have an additional role 
in the later stages of LIRE when secondary neutrophil invasion can 
occur after endothelial injury. Moreover, compensatory effects of 
p47phox deficiency even after bone marrow transplantation cannot 
be excluded. In contrast, such effects are most unlikely in our induc-
ible endothelial cell-specific Nox2-knockout mice.
To decipher the underlying signalling cascade of LIRE, we next dem-
onstrated a lack of intravascular superoxide release in Nox2y/ −  mice 
during ischaemia–reperfusion. Focusing on primary endothelial cells 
from Nox2y/ −  mice and the corresponding WT strain, we confirmed 
extracellular  superoxide  production  during  ischaemia–reperfusion. 
Possibly, activation of Nox2 during ischaemia occurs via Rac1 activa-
tion or mechanotransduction and membrane depolarization38–40.
Measurement of intra- and extracellular H2O2 levels upon appli-
cation of extracellular superoxide dismutase or catalase, suggested 
that  extracellular  superoxide  is  converted  to  H2O2  and  induces 
ischaemia–reperfusion-induced increase of vascular permeability 
upon diffusion into MLEC. Moreover, our data indicate that H2O2 
already starts to increase during ischaemia, consistent with a similar 
kinetics of the [Ca2 + ]i rise found in MLEC.
In  TRPC6-deficient  endothelial  cells,  the  rise  in  [Ca2 + ]i  was 
attenuated when compared with WT cells. Contrary to previous   
reports  (reviewed  in  Mehta  and  Malik  41),  emptying  of  inter-
nal calcium stores was not responsible for the rise in ischaemia–
reperfusion-induced [Ca2 + ]i as shown by our experiments under 
conditions of extracellular Ca2 +  deprivation. In this context, it is 
important to mention that members of the TRPC family can act 
as  receptor-operated  or  store-operated  channels  and  have  been 
identified in endothelial cells by several research groups41–43. The 
exclusive role of TRPC6 channels in LIRE was further confirmed by 
the fact that deletion of other TRPC channels, TRPC1 and TRPC4, 
which are also prominently expressed in lung endothelial cells, do 
not protect from LIRE in the intact organ.
To address the issue as to how Nox2-mediated ROS generation 
activates TRPC6 channels during LIRE, we subsequently focused on 
DAG. It has previously been demonstrated that TRPC6 can be acti-
vated by DAG and that the DAG-generating PLC isoenzyme PLCγ 
can be stimulated by H2O2
28. We found that activated phospho-
PLCγ was increased in lungs exposed to ischaemia–reperfusion, as 
well as in MLEC, after exposure to H2O2. PLCγ phosphorylation 
in ischaemia–reperfusion was dependent on Nox2 function, as it 
was not found in Nox2y/ −  lungs. Moreover, application of ischae-
mia to endothelial cells resulted in DAG accumulation, which is at 
least partially caused by the inhibition of DAG kinase η isoforms, 
degrading DAG to phosphatidic acid44. OAG administration and 
DAG kinase inhibition in intact lungs mimicked DAG accumula-
tion and consequently LIRE in normoxic lungs. Furthermore, OAG 
reversed  the  protection  against  ischaemia–reperfusion-induced 
increase of vascular permeability in Nox2y/ −  mice.
In conclusion, Nox2 and TRPC6 have a hitherto unappreciated, 
indispensable role in the development of LIRE in mice. Deciphering   
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the  signalling  cascade  from  Nox2  activation  to  ROS-mediated, 
DAG-dependent  TRPC6  activation  and  subsequent  increases  in 
lung endothelial permeability and oedema (summarized in Fig. 7c) 
provides new insight into the pathophysiology of the early stages 
of LIRE. If future experiments in human lungs indicate that our 
findings are transferable to the human situation, this may offer new 
promising strategies to suppress the progression of LIRE in the clin-
ical setting.
Methods
Animals. All animal experiments were approved by the governmental authori-
ties (Regierungspräsidium Giessen). As genes for Nox1 and Nox2 are located 
on the X chromosome, male mice carrying a mutated allele on their single X 
chromosomes were used and labelled as Nox1y/ −  and Nox2y/ −  mice throughout 
the manuscript. TRPC6 − / − , Nox1y/ −  and Nox4 − / −  mice were generated as previ-
ously described27,45,46. C57Bl/6 and Nox2y/ −  mice were purchased from Jackson 
Laboratories21. Mice deficient for Nox2 either in cells of the myeloid lineage or 
tamoxifen-inducible in endothelial cells were generated by crossing C57BL/6-TG-
Nox2Flox/Flox with the appropriate Cre-deleter mice.
Generation of mice deficient for Nox2. Mice deficient for Nox2 either in cells of 
the myeloid lineage or tamoxifen-inducible in endothelial cells were generated by 
crossing C57BL/6-TG-Nox2-Flox/Flox C57BL/6-TG-Lysm-Cre + /0 and C57BL/6-
TG-ERT2-Tie2-Cre + /0, respectively, as provided by the co-authors 47. Offsprings 
were crossed and bred homozygous for the Flox allele and by mating 0/ + ×0/0 of 
the Cre-line in the Flox-background hemizygous or null for the Cre construct. To 
induce endothelial-specific deletion of Nox2, mice receive injections of tamoxifen 
(40 mg kg − 1, 100 µl intraperitoneally of a solution of 1 mg ml − 1 tamoxifen dis-
solved in 90% corn oil, 10% ethanol) on three consecutive days and experiments 
were performed 7 days after the last tamoxifen injection.
Analysis of ischaemia–reperfusion-induced oedema in living mice.  
The Nox2y/ − , TRPC6 − / −  or corresponding WT mice were anaesthetized by 
intraperitoneal injection of ketamine (100 mg kg − 1) and xylazine (8 mg kg − 1). 
Mice were placed in a heating chamber to maintain body temperature (37 °C) 
during the entire experiment. Endotracheal intubation with a 21-gauge atraumatic 
cannula was performed by tracheotomy, and mechanical ventilation was initiated 
(130 breaths per min, 225 µl stroke volume, and a positive-end expiratory pressure 
of 2 cm H2O) with an inspiratory oxygen fraction of 50%, using a mouse ventilator 
MiniVent type 845 (Hugo Sachs Elektronik, March-Hugstetten, Germany). After a 
left anterolateral thoracotomy through the third left intercostal space, all animals 
were given 500 IU kg − 1 heparin. Five minutes after heparin administration, the 
pulmonary hilum of the left lung, including the bronchus, pulmonary artery and 
pulmonary vein, was occluded for 90 min using a non-crushing microsurgical 
clamp to cause pulmonary ischaemia of the left lung in an inflated state. Upon 
removal of the clamp, the left lung was reperfused and reventilated for 90 min. The 
PLC inhibitor U-73122 (2.5 mg kg − 1) or vehicle were administered to WT mice via 
tail vein 10 min before starting ischaemia. In time-matched sham-operated animals 
serving as controls, thoracotomy was performed without occlusion of the hilum. 
In this group, U-73122 or vehicle were administered into WT mice via the tail 
vein at a time point corresponding to that in ischaemia–reperfusion groups. At the 
end of the reperfusion period, animals were killed, and left lungs were excised for 
assessment of tissue water content. As a measure of pulmonary oedema formation, 
wet-to-dry lung weight ratios were determined for left lungs. For this purpose, total 
lung weight was measured before (wet weight) and after a 48-h drying process  
(dry weight) and values were normalized to sham-operated controls.
Isolation and culture of murine endothelial cells. MLEC were isolated from the 
lungs of five mice (WT and TRPC6 − / − ). After explantation of the lungs, tissue 
slices of 1 mm were prepared in a cell culture hood and washed in Hanks’ balanced 
salt solution (HBSS, containing 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM 
CaCl2, 5 mM glucose in 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (HEPES) buffer (pH 7.4)) to remove remaining blood. Minced tissues were 
transferred to a sterile 50-ml tube containing 20 ml HBSS without Ca2 +  and Mg2 +  
and dispase (1 U ml − 1), and digested for 60 min at 37 °C with gentle shaking. After 
releasing cells from the tissue by continuous pipetting, residual tissue was removed 
by filtering the suspension through a 70-µm mesh filter. The filtered cell suspension 
was centrifuged at 290 g, and cells were washed in 5 ml HBSS + 0.5% bovine serum 
albumin (HBSS/BSA). Cells were then resuspended in 800 µl HBSS/BSA and  
25 µl (4×105 beads per µl) Dynabeads M-450 (Sheep anti-rat IgG, Invitrogen) 
coated with 1.5 µg anti-mouse CD144 antibody produced in rat (BD Pharmingen). 
Cells were incubated in an end-over-end shaker at room temperature for 30 min 
and unbound cells were removed by washing five times with HBSS/BSA, using a 
magnetic device (Dynal MPC-1, Invitrogen). Cells were plated onto fibronectin-
coated cell culture dishes, cultured in endothelial cell growth medium (C-22020, 
Promocell, Heidelberg, Germany) supplemented with 15% fetal calf serum (PAA, 
Cölbe, Germany) and allowed to grow to confluency for 7–10 days. Cells were 
washed with HBSS/BSA and further purified by adding CD144-coated Dynabeads 
M-450 in HBSS/BSA, directly to the cell culture dish for 60 min. After trypsiniza-
tion, unbound cells were removed by washing with HBSS/BSA, using the magnetic 
device as described above. The identity of endothelial cells was confirmed by stain-
ing with an antibody directed against von-Willebrand factor (number 1284924, 
Boehringer Mannheim, Mannheim, Germany) and platelet endothelial cell adhe-
sion molecule-1 (M20 SC-1506, Santa Cruz Biotechnology, Santa Cruz, USA). An 
immunoblot with a TRPC6-specific antiserum (gift of V. Flockerzi) demonstrated 
the absence of the TRPC6 protein in endothelial cells of TRPC6-deficient mice.
Determination of intracellular H2O2 in MLEC. For intracellular H2O2 detec-
tion, the coding information for the H2O2-sensitive, enhanced yellow fluorescent 
protein variant HyPer48 was subcloned under the control of the EF-1α enhancer/
promoter into the pWPXL plasmid (distributed by Addgene, Boston) and packed 
with a second-generation lentivirus transduction system (see http://tronolab.
epfl.ch/ for more details). Infections were carried out with a titre of at least 1×107 
particles according to established protocols (see http://tronolab.epfl.ch/ for more 
details). The optimal HyPer signal-to-noise ratio was determined by acquiring con-
tinuous excitation–emission spectra in the presence or absence of 100-µM H2O2 
(data not shown). Experiments were carried out as outlined for  the [Ca2 + ]i- 
imaging and Mn2 + -quench experiments in MLEC, but with 420 and 470 nm  
wavelength as excitation parameters.
ESR spectroscopy measurements. Superoxide generation in isolated lungs 
was measured by ESR spectroscopy, using the spin probe 1-hydroxy-3-carboxy-
2,2,5,5-tetramethylpyrrolidine (CPH, Alexis Corporation, San Diego, CA, USA), as 
described 49. Briefly, stock solutions of CPH (10 mmol l − 1) dissolved in 0.9% NaCl 
that contained 1 mmol l − 1 diethylenetriamine-pentaacetic acid, and was purged 
with argon, were prepared daily and kept under argon on ice. Diethylenetriamine-
pentaacetic acid was used to decrease CPH autoxidation, which is catalysed by 
trace amounts of transition metals. Isolated mouse lungs were perfused with Krebs-
HEPES buffer and then pretreated for 4 h with 50 g l − 1 Chelex 100 to minimize 
transition metal contamination. Lungs from WT, Nox2y/ −  or chimeric mice were 
exposed to anoxic ischaemia for 90 min. The spin probe, CPH (0.5 mmol l − 1), was 
added into the perfusate 5 min before the onset of reperfusion. Samples from the 
venous outflow of the isolated lung were collected in 50-µl glass capillary tubes 
and measured immediately at room temperature. Samples were collected every 15 s 
during the first 3 min of reperfusion and then every 1 min or 5 min, as appropriate. 
Experiments were also carried out in time-matched non-ischaemic control lungs. 
The triple-line spectrum of 3-carboxy-proxyl radical (CP•) was detected using an 
MS100 spectrometer (Magnettech, Berlin, Germany). The ESR settings were as 
follows: microwave frequency, 9.78 GHz; modulation frequency, 100 kHz; modula-
tion amplitude, 2 G; microwave power, 18 mW. The quantity of trapped ROS was 
directly calculated from the change of the ESR signal intensity during the first 
5 min of reperfusion. The superoxide portion of the ESR signal was calculated as 
the difference between the ROS release in the presence and absence of superoxide 
dismutase in buffer fluid (150 U ml − 1).
For the determination of superoxide generation by MLEC, cells were 
trypsinized and centrifuged at 320 g for 5 min. Supernatant was discarded and the 
sediment was resuspended and washed two times in ESR-Krebs HEPES buffer 
(Noxygen Science Transfer & Diagnostics GmbH, Germany). Samples were 
adjusted to cell numbers and incubated for 2 h at 37 °C. Incubation of parallel 
samples with superoxide dismutase (15 U ml − 1, Sigma-Aldrich, Germany) allowed 
calculation of the superoxide portion of the ESR signal. All samples were treated 
with CPH for 30 min at 37 °C. Measurements were performed using the Bruker 
EMX micro Spectrometer (Bruker Biospin, Steinheim, Germany).
Electric cell impedance sensing (ECIS). Hypoxia-induced changes in endothelial 
resistance were analysed using an ECIS flow device (Applied Biophysics, Troy, 
USA). Impedance arrays (8F1E) were incubated with endothelial cell medium 
overnight. A total of 20,000 endothelial cells were seeded per well and grown for 
48 h at 37 °C and 5% CO2 in an incubator. Medium was removed, HBSS was added 
to the cells, and the array was connected to the ECIS device. HBSS was exchanged 
to HBSS gassed with N2 as soon as impedance was stable. Resistance (Ω) was 
analysed for 3–5 h. 
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